{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:19:15Z","timestamp":1773659955903,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1157\/13088411","type":"journal-article","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T10:04:29Z","timestamp":1153217069000},"page":"159-165","source":"Crossref","is-referenced-by-count":10,"title":["Disminuci\u00f3n del transportador de dopamina estriatal en primeros episodios psic\u00f3ticos de pacientes esquizofr\u00e9nicos tratados con risperidona"],"prefix":"10.1016","volume":"25","author":[{"given":"J.J.","family":"Mateos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lome\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Font","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pavia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Prats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13088411_bib1","series-title":"Principios de Medicina Interna","author":"Harrison","year":"1989"},{"key":"10.1157\/13088411_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3956(98)00023-5","article-title":"New atypical antipsychotic medicatios","volume":"32","author":"Jibson","year":"1998","journal-title":"J Psychiatry Res"},{"key":"10.1157\/13088411_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00007611-199005000-00011","article-title":"Neuroleptic approach to drug-induced movement disorders: a study of 125 patients","volume":"83","author":"Miller","year":"1990","journal-title":"South Med J"},{"key":"10.1157\/13088411_bib4","series-title":"Dementia praecox or the group of schizophrenias","author":"Bleuler","year":"1950"},{"key":"10.1157\/13088411_bib5","series-title":"Dementia praecox and paraphrenia","author":"Kraeplin","year":"1919"},{"key":"10.1157\/13088411_bib6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1176\/ajp.150.9.1343","article-title":"Parkinsonism in neuroleptic-na\u00efve schizophrenic patients","volume":"150","author":"Caliguri","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1157\/13088411_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1192\/bjp.168.2.221","article-title":"Abnormal movements in never medicated Indian patients with schizophrenia","volume":"168","author":"McCreadie","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1157\/13088411_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S0007125000161859","article-title":"Spontaneous dyskinesia and parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-up","volume":"181","author":"McCreadie","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1157\/13088411_bib9","first-page":"269","article-title":"S\u00edntomas extrapiramidales en pacientes esquizofr\u00e9nicos nunca tratados con neurol\u00e9pticos","volume":"4","author":"Peralta","year":"2002","journal-title":"Aula M\u00e9dica Psiqui\u00e1trica"},{"key":"10.1157\/13088411_bib10","first-page":"304","article-title":"Motor deficits and schizophrenia: the evidence from neuroleptic-na\u00efve patients and populations at risk","volume":"24","author":"Wolff","year":"1999","journal-title":"J Psychiatry Neurosc"},{"key":"10.1157\/13088411_bib11","first-page":"1203","article-title":"From noncompliance to collaboration in the treatment of schizophrenia","volume":"41","author":"Corrigan","year":"1990","journal-title":"Hosp Community Psychiatry"},{"key":"10.1157\/13088411_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0925-4927(01)00085-3","article-title":"Double-blind olanzapine vs haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint","volume":"107","author":"Bernardo","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1157\/13088411_bib13","first-page":"1028","article-title":"D2 receptor occupancy during high-and lowdose therapy with the atypical antipsychotic amisulpiride: a 123I-iodobenzamide SPECT study","volume":"46","author":"La Fougere","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1157\/13088411_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-7091-6842-4_2","article-title":"Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy","volume":"50","author":"Br\u00fccke","year":"1997","journal-title":"J Neural Transm (Supl)"},{"key":"10.1157\/13088411_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00006231-200107000-00015","article-title":"Imaging of the dopaminergic system in parkinsonism with SPECT","volume":"22","author":"Tatsch","year":"2001","journal-title":"Nucl Med Commun"},{"key":"10.1157\/13088411_bib16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002590000460","article-title":"The clinical benefit of imaging striatal dopamine transporters with [123I] FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism","volume":"28","author":"Booij","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1157\/13088411_bib17","first-page":"1143","article-title":"Iodine-123-N-omega-fluoropropyl-2betacarbomethoxy-ebeta-(4-iodophenyl)-tropane SPECT in healthy controls and early-stage, drug-na\u00efve Parkinson's disease","volume":"39","author":"Tissingh","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1157\/13088411_bib18","series-title":"Structured Clinical Interview for DSM-IV- Patients edition (SCID-P)","author":"First","year":"1994"},{"key":"10.1157\/13088411_bib19","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1157\/13088411_bib20","volume":"76","author":"Guy","year":"1976"},{"key":"10.1157\/13088411_bib21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1157\/13088411_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extra-pyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Act Psychiatry Scan (Supl)"},{"key":"10.1157\/13088411_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002590050374","article-title":"Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism","volume":"26","author":"Booij","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1157\/13088411_bib24","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/mds.20112","article-title":"Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian Symdromes","volume":"19","author":"Catafau","year":"2004","journal-title":"Mov Disord"},{"key":"10.1157\/13088411_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130051163","article-title":"Radiotracers imaging of dopaminergic transmission in neuropsychiatric disorders","volume":"147","author":"Verhoeff","year":"1999","journal-title":"Psychopharmacoloy"},{"key":"10.1157\/13088411_bib26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1212\/WNL.43.3_Part_1.552","article-title":"Nigral dysfunction in drug-induced Parkinsonism: an 18F-DOPA PET study","volume":"43","author":"Burn","year":"1993","journal-title":"Neurology"},{"key":"10.1157\/13088411_bib27","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/archneur.1982.00510220042009","article-title":"Reversible drug-induced parkinsonism. Clinicopathologis study of two cases","volume":"10","author":"Rajput","year":"1982","journal-title":"Arch Neurol"},{"key":"10.1157\/13088411_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-9964(00)00095-5","article-title":"Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia","volume":"52","author":"Laakso","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1157\/13088411_bib29","first-page":"31","article-title":"Decrease of dopamine transporter binding in neuroleptic-free schizophrenic patients assessed with IPT-SPECT (abstr.?","volume":"40","author":"Tatsch","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1157\/13088411_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/schbul\/16.1.97","article-title":"Dopaminergic mechanisms in idiopathic and drug-induced psychoses","volume":"16","author":"Lieberman","year":"1990","journal-title":"Schizophr Bull"},{"key":"10.1157\/13088411_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1176\/appi.ajp.157.2.269","article-title":"Striatal dopamine transporter binding in neuroleptic na\u00efve patients with schizophrenia studied with PET","volume":"157","author":"Laakso","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1157\/13088411_bib32","first-page":"371","article-title":"Dopamine and serotonin transporter in patients with schizophrenia: an imaging study with 123I-(CIT. Biol","volume":"47","author":"Laruelle","year":"2000","journal-title":"Psychiatry"},{"key":"10.1157\/13088411_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0920-9964(00)00023-2","article-title":"Dopamine transporter density in young patients with schizophrenia assessed with [123I] FP-CIT SPECT","volume":"47","author":"Lavalaye","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1157\/13088411_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-003-1700-y","article-title":"123I-(-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia","volume":"173","author":"Sjoholm","year":"2004","journal-title":"Psychopharmacol"},{"key":"10.1157\/13088411_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(95)00611-S","article-title":"Brain dopamine transporter: gender differences and effect of chronic haloperidol","volume":"692","author":"Rivest","year":"1995","journal-title":"Brain Res"},{"key":"10.1157\/13088411_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1022405621365","article-title":"Neuroleptics and dopamine transporters","volume":"23","author":"Reader","year":"1998","journal-title":"Neurochem Res"},{"key":"10.1157\/13088411_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-2999(84)90403-5","article-title":"Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake","volume":"104","author":"Richelson","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1157\/13088411_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-2999(95)00770-9","article-title":"Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter","volume":"298","author":"Gordon","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1157\/13088411_bib39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1471-4159.1993.tb03174.x","article-title":"Comparison of 3HWIN 35,428 binding, a marker for dopamine transporter, in embrionyc mesencephalic neuronal cultures with striatal membranes of adult rats","volume":"60","author":"Valchar","year":"1993","journal-title":"J Neurochem"},{"key":"10.1157\/13088411_bib40","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1523\/JNEUROSCI.18-15-05901.1998","article-title":"DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18] fluorodopa positron emission tomography study","volume":"18","author":"Ernst","year":"1998","journal-title":"J Neurosci"},{"key":"10.1157\/13088411_bib41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s002590000279","article-title":"Effect of age and gender on dopamine transporter imaging with [123I] FP-CIT SPECT in healthy volunteers","volume":"27","author":"Lavalaye","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1157\/13088411_bib42","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1176\/ajp.154.12.1641","article-title":"Psychopathology in women and men: focus on female hormones","volume":"154","author":"Seeman","year":"1997","journal-title":"Am J Psychiatry"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698206750182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698206750182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T03:12:20Z","timestamp":1555729940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212698206750182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0212698206750182"],"URL":"https:\/\/doi.org\/10.1157\/13088411","relation":{},"ISSN":["0212-6982"],"issn-type":[{"value":"0212-6982","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}